REQUEST A DEMO
Total
USD $0.00
Search more companies

Changjiang Pharmaceutical Group Co.,Ltd. (China)

Main Activities: Engine, Turbine, and Power Transmission Equipment Manufacturing
Full name: Changjiang Pharmaceutical Group Co.,Ltd. Profile Updated: November 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Changjiang Pharmaceutical Group Co., Ltd. is a national high-tech enterprise that specializes in the research, manufacturing, and sales of internal combustion engine turbochargers. The company's 3GJs-1 turbocharger has been recognized as a national-level new product. Their JP50S gasoline engine turbocharger is listed as a national torch plan project and has received the second prize of the China Industrial Machinery Science and Technology Award. The KT60S dual-channel variable cross-section turbocharger has been awarded the second prize of the Shandong Province Science and Technology Progress Award. Several other products, such as the HP60S electric-assisted turbocharger and JP30S gasoline engine turbocharger, have been recognized through provincial and municipal-level scientific and technological achievements evaluations, reaching leading domestic or international levels. The company has participated in the drafting of two turbocharger industry standards and national standards. It has been recognized as an outstanding contributor in the internal combustion engine industry, a leading enterprise in the automotive turbocharger sector, and a pioneer in the internal combustion engine parts industry in China. The company has received awards such as the China Internal Combustion Engine Industry Centennial Achievement Award, the Gold Award at the Shandong Province Industry-University-Research Cooperation Exhibition and Trade Fair, and the Shandong Province Enterprise Technological Innovation Award.

Headquarters
No. 69, Tianma Avenue, Yunyang Economic Development Zone, Shiyan City, Hubei Province
Shiyan; Hubei; Postal Code: 442500

Contact Details: Purchase the Changjiang Pharmaceutical Group Co.,Ltd. report to view the information.

Website: http://www.chinakangyue.com

Basic Information
Total Employees:
Purchase the Changjiang Pharmaceutical Group Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Changjiang Pharmaceutical Group Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Changjiang Pharmaceutical Group Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Changjiang Pharmaceutical Group Co.,Ltd. report to view the information.
Incorporation Date:
December 24, 2001
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
10.11%
Purchase this report to view the information.
5.99%
Purchase this report to view the information.
5.05%
Purchase this report to view the information.
3.86%
Purchase this report to view the information.
0.83%
Subsidiaries
Changyao (Hubei) Health Industry Co., Ltd
100%
Changyao (Shouguang) Health Industry Co., Ltd
100%
Enshi Mingqun Health Pharmaceutical Industry Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Changjiang Pharmaceutical Group Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-90.12%
Total operating revenue
-90.12%
Operating profit (EBIT)
-41.49%
Net Profit (Loss) for the Period
-103.58%
Total assets
-17.41%
Total equity
-53.55%
Operating Profit Margin (ROS)
-254.75%
Net Profit Margin
-263.86%
Return on Equity (ROE)
-29.32%
Debt to Equity Ratio
42.41%
Quick Ratio
-0.1%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?